Iron is an essential mineral that plays a crucial role in the body's function. One of its primary functions is to help produce hemoglobin, the protein in red blood cells that binds oxygen and transports it from the lungs to tissues throughout the body. Without enough iron, the body cannot produce an adequate amount of hemoglobin, leading to decreased oxygen delivery to tissues and organs, resulting in symptoms of anemia. The active ingredient in ferric carboxymaltose is iron (III) hydroxide complexed with carboxymaltose, a carbohydrate polymer derived from starch. This complex allows for the slow release of iron, providing a sustained source of iron for utilization by the body.
However, like any medication, ferric carboxymaltose may cause side effects in some individuals. Common side effects may include headache, dizziness, nausea, vomiting, or injection site reactions (such as pain, swelling, or redness). These side effects are usually mild to moderate in severity and typically resolve on their own without the need for intervention. In rare cases, individuals may experience more serious side effects, such as severe allergic reactions (anaphylaxis) or hypophosphatemia
Before receiving ferric carboxymaltose, patients should inform their healthcare providers about any allergies, medical conditions, or medications they are taking, as well as any history of iron overload disorders (e.g., hemochromatosis) or previous adverse reactions to intravenous iron therapy.